1. Home
  2. ULY vs PPBT Comparison

ULY vs PPBT Comparison

Compare ULY & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ULY
  • PPBT
  • Stock Information
  • Founded
  • ULY 2013
  • PPBT 2010
  • Country
  • ULY United States
  • PPBT Israel
  • Employees
  • ULY N/A
  • PPBT N/A
  • Industry
  • ULY
  • PPBT Biotechnology: Pharmaceutical Preparations
  • Sector
  • ULY
  • PPBT Health Care
  • Exchange
  • ULY Nasdaq
  • PPBT Nasdaq
  • Market Cap
  • ULY 6.0M
  • PPBT 6.5M
  • IPO Year
  • ULY N/A
  • PPBT N/A
  • Fundamental
  • Price
  • ULY $7.37
  • PPBT $2.27
  • Analyst Decision
  • ULY Strong Buy
  • PPBT Strong Buy
  • Analyst Count
  • ULY 1
  • PPBT 1
  • Target Price
  • ULY $12.00
  • PPBT $33.00
  • AVG Volume (30 Days)
  • ULY 363.5K
  • PPBT 286.5K
  • Earning Date
  • ULY 05-13-2025
  • PPBT 05-23-2025
  • Dividend Yield
  • ULY N/A
  • PPBT N/A
  • EPS Growth
  • ULY N/A
  • PPBT N/A
  • EPS
  • ULY N/A
  • PPBT N/A
  • Revenue
  • ULY $134,085,000.00
  • PPBT N/A
  • Revenue This Year
  • ULY N/A
  • PPBT N/A
  • Revenue Next Year
  • ULY $17.87
  • PPBT N/A
  • P/E Ratio
  • ULY N/A
  • PPBT N/A
  • Revenue Growth
  • ULY N/A
  • PPBT N/A
  • 52 Week Low
  • ULY $2.99
  • PPBT $2.00
  • 52 Week High
  • ULY $32.04
  • PPBT $20.60
  • Technical
  • Relative Strength Index (RSI)
  • ULY 47.27
  • PPBT 40.43
  • Support Level
  • ULY $4.54
  • PPBT $2.18
  • Resistance Level
  • ULY $11.80
  • PPBT $2.41
  • Average True Range (ATR)
  • ULY 2.45
  • PPBT 0.20
  • MACD
  • ULY -0.41
  • PPBT -0.01
  • Stochastic Oscillator
  • ULY 5.77
  • PPBT 27.96

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.

Share on Social Networks: